Bacitracin Zinc And Polymyxin B Sulfate Ointment
NDC Package 24208-555-55
Package Information
Bacitracin Zinc And Polymyxin B Sulfate ointment is a medication contraindicated in those individuals who have shown hypersensitivity to any of its components. This formulation utilizes a ointment delivery system. Marketed by Bausch & Lomb Incorporated, this product is identified by NDC 24208-555 and is authorized under FDA application ANDA064046.
Identification & Billing
- RxCUI: 308511 - bacitracin zinc 500 UNT / polymyxin B sulfate 10,000 UNT per GM Ophthalmic Ointment
- RxCUI: 308511 - bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment
- RxCUI: 308511 - bacitracin (as bacitracin zinc) 500 UNT / polymyxin B (as polymyxin B sulfate) 10,000 UNT per GM Ophthalmic Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 24208 - Bausch & Lomb Incorporated
- 24208-555 - Bacitracin Zinc And Polymyxin B Sulfate
- 24208-555-55 - 1 TUBE in 1 CARTON / 3.5 g in 1 TUBE
- 24208-555 - Bacitracin Zinc And Polymyxin B Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 24208-555-55 identifies a specific commercial package of 1 tube in 1 carton / 3.5 g in 1 tube of Bacitracin Zinc And Polymyxin B Sulfate, a human prescription drug labeled by Bausch & Lomb Incorporated. This ointment is formulated for ophthalmic use and contains bacitracin zinc; polymyxin b sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch & Lomb Incorporated on April 25, 2008. The current certification is valid through December 31, 2026.
How is this Bausch & Lomb Incorporated product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 24208055555. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 3.5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.